Industry News
AusBiotech Business Development Forum 2013
Registration is now open for the 2013 AusBiotech Business Development Workshop and Forum, which will be held in Adelaide from 20-21 March. [ + ]
Science Academy welcomes commitment to protect Australia’s medical research
The Australian Academy of Science has welcomed a commitment by Tony Abbott and Peter Dutton to protect the nation’s health and medical research budget. [ + ]
One-step test for mitochondrial diseases
More powerful gene-sequencing tools have increasingly been uncovering disease secrets in DNA within the cell nucleus. Now a research team is expanding those rapid next-generation sequencing tests to analyse the DNA that is within the genes inside mitochondria. [ + ]
Plexon celebrates 30 years in neuroscience research, record sales and a new website
Plexon, a leader in hardware and software solutions for neuroscience and behavioural research, has marked 30 years of innovation on the heels of closing its strongest year. [ + ]
AtCor forecasts profit in 2013
Medical device manufacturer AtCor (ASX:ACG) expects to report a profit in this financial year following strong sales of its SphygmoCor diagnostic device. [ + ]
Biotechs up after All Ordinaries surge
Life science stocks have enjoyed a boost alongside the broader share market, with stocks such as CSL (ASX:CSL) hitting historic highs. [ + ]
Victorian Infection and Immunity Network gets $300K injection from Vic government
A collaborative network of researchers in infection and immunity has received a $300,000 grant from the Victorian government to encourage industry partnerships. [ + ]
Immune cell death defects linked to autoimmune diseases
Melbourne researchers have discovered that the death of immune system cells is an important safeguard against the development of diseases such as type 1 diabetes, rheumatoid arthritis and lupus, which occur when the immune system attacks the body’s own tissues. [ + ]
Discovery shows genetic causes of rare bone condition
Researchers at the University of Oxford have discovered two new genetic causes of craniosynostosis, a rare bone condition that can inhibit brain growth in children. [ + ]
ResMed revenues up thanks to strong sales
ResMed (ASX:RMD) has seen revenues increase by 13% for the December quarter year on year with a dividend coming in February. [ + ]
World’s smallest spanner puts a new twist on microscopic manipulation
By harnessing laser light’s ability to gently push and pull microscopic particles, researchers have created the fibre-optic equivalent of the world’s smallest spanner. [ + ]
Researchers identify enzyme involved in deadly brain tumours
In a study published in Neuro-Oncology, researchers at Mayo Clinic identify an important association between the naturally occurring enzyme Kallikrein 6, also known as KLK6, and the malignant tumour glioblastoma multiforme. [ + ]
Cellmid antibodies reduced kidney damage in mice
Cellmid’s (ASX:CDY) anti-midkine antibodies were able to reduce kidney damage and preserve function in an animal model of diabetic nephropathy. [ + ]
Uscom protocol slashed sepsis deaths: study
A Bathurst hospital reduced sepsis-related deaths by 94% by adopting a treatment protocol involving the use of Uscom (ASX:UCM) diagnostics tech, according to a new study. [ + ]
Allied Healthcare closes $4.6m capital raising
Allied Healthcare (ASX:AHZ) will put the $4.6m raised in a placement and SPP towards launching its CardioCel heart patch as well as phase I trials of its DNA vaccine against herpes. [ + ]
